[A view of care pathways approved by Italian Regions, to face the challenge of the community-based healthcare: a quali-quantitative analysis of the Pdta Net database.]

Conoscere i percorsi diagnostico-terapeutici assistenziali (Pdta) regionali approvati in Italia per affrontare il cambiamento della assistenza di prossimità: analisi quali-quantitativa del database Pdta Net.

Journal

Recenti progressi in medicina
ISSN: 2038-1840
Titre abrégé: Recenti Prog Med
Pays: Italy
ID NLM: 0401271

Informations de publication

Date de publication:
01 2023
Historique:
entrez: 27 12 2022
pubmed: 28 12 2022
medline: 29 12 2022
Statut: ppublish

Résumé

The adoption of a Care Pathway (CP) allows the healthcare management of patients suffering from high-epidemiological impact chronic diseases. The continuity of care of these patients is one of the main purposes of the community-based healthcare reform, foreseen in the 6th Mission of the National recovery and resilience plan. Fondazio-ne Ricerca e Salute (ReS) collects and analyses regional CPs approved in Italy, through the Pdta Net database. Fondazione ReS has retrieved all the CPs approved by Italian Regions and Autonomous provinces until 12/31/2021 within institutional websites, through specific keywords. The quali- and quantitative analysis of CPs was based on the approving Region, the publication year, the disease (distinguishing between high-epidemiological impact chronic diseases and rare conditions) and clinical area. Following the 5-year experience gained by Fondazione ReS in terms of CPs' aims and organization for the full realization of an evidence-based healthcare of chronic patients, all data collected until 12/31/2021 underwent an in-depth double-blinded quality control. This control was aimed to make the Pdta Net database as representative as possible of the existing documents closest to a real CP. From 2005 to 2021, 729 regional CPs have been approved: 404 on high-impact chronic diseases and 220 on rare conditions. The CPs of chronic diseases, mostly edited by Piemonte (45 CPs), Campania (34) and Toscana (33) Regions, mainly concern on diabetes (19), chronic obstructive pulmonary disease (15), heart failure (13), stroke, multiple sclerosis and colorectal neoplasms (12 each one), breast cancer (11), dementia and chronic kidney disease (10 each one). Most of the CPs on rare diseases have been edited by Regions with an established Rare Disease Network, i.e., Lombardia (125 CPs), Lazio (74) and Toscana (40): neurology (61) and oncology (52) were the most represented clinical areas. The high number of CPs approved in Italy confirms an increasing interest of the healthcare institutions. The collected CPs show an extreme variety of titles, text structures and disease choices. Given the absence of an institutional observatory and of devotees of shared and harmonized CPs, annually Pdta Net makes available an updated and complete overview of these governance tools, which are essential for the upcoming changes of the Italian national health service.

Identifiants

pubmed: 36573531
doi: 10.1701/3939.39228
doi:

Types de publication

English Abstract Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

792-801

Auteurs

Irene Dell'Anno (I)

Fondazione Ricerca e Salute (ReS), Roma.

Silvia Calabria (S)

Fondazione Ricerca e Salute (ReS), Roma.

Letizia Dondi (L)

Fondazione Ricerca e Salute (ReS), Roma.

Giulia Ronconi (G)

Fondazione Ricerca e Salute (ReS), Roma.

Leonardo Dondi (L)

Fondazione Ricerca e Salute (ReS), Roma.

Alice Addesi (A)

Drugs and Health Srl, Roma.

Antonella Pedrini (A)

Fondazione Ricerca e Salute (ReS), Roma.

Immacolata Esposito (I)

Drugs and Health Srl, Roma.

Aldo Pietro Maggioni (AP)

Fondazione Ricerca e Salute (ReS), Roma.

Nello Martini (N)

Fondazione Ricerca e Salute (ReS), Roma.

Carlo Piccinni (C)

Fondazione Ricerca e Salute (ReS), Roma.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH